Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SPYM vs MRNA✓SelectedUSD · MRNASPYM vs MRNA performance historyLatest closeAs of-3.55%11/20
Stock and ETF performance explorer

SPYM vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+58.4%
MRNA return
-27.3%
Excess return
+85.7%
Maximum drawdown
-24.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-3.5%-2.2%-1.4%-3.5%
7D-8.4%-12.7%+4.3%-8.0%
30D-10.7%-20.7%+10.0%-10.0%
3M-9.2%+46.3%-55.5%-10.8%
6M-6.4%+305.2%-311.6%-16.2%
YTD+2.1%+561.2%-559.1%-13.8%
1Y+7.0%+772.1%-765.1%-12.4%
3Y+58.0%+147.0%-89.0%+40.3%
All+58.4%-27.3%+85.7%+46.6%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling